You are here:
Publication details
Tyrosine-kinase inhibitors (TKI) in first-line treatment of 470 patients with non-small cell lung cancer (NSCLC) from the Czech Republic
Authors | |
---|---|
Year of publication | 2019 |
Type | Conference abstract |
Citation |